Clinical Trial Update: REaCT Integrated Consent Model to Compare Two Standard of Care Regimens [Phase 4]

View source ↗

Summary

This Phase 4 study evaluates an integrated consent model for comparing two standard-of-care regimens in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED